These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21896780)

  • 21. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
    Marks JL; Gong Y; Chitale D; Golas B; McLellan MD; Kasai Y; Ding L; Mardis ER; Wilson RK; Solit D; Levine R; Michel K; Thomas RK; Rusch VW; Ladanyi M; Pao W
    Cancer Res; 2008 Jul; 68(14):5524-8. PubMed ID: 18632602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells.
    Sun KK; Ji C; Li X; Zhang L; Deng J; Zhong N; Wu XY
    Mol Med Rep; 2013 May; 7(5):1678-82. PubMed ID: 23467607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.
    Ma X; Huang J; Tian Y; Chen Y; Yang Y; Zhang X; Zhang F; Xue L
    Oncogene; 2017 Jun; 36(22):3159-3167. PubMed ID: 28068320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.
    Pavese JM; Ogden IM; Voll EA; Huang X; Xu L; Jovanovic B; Bergan RC
    PLoS One; 2014; 9(7):e102289. PubMed ID: 25019290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
    Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
    Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.
    Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH
    Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
    Wu X; Gong Z; Sun L; Ma L; Wang Q
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.
    Finegan KG; Tournier C
    Cancer Res; 2010 Jul; 70(14):5797-806. PubMed ID: 20610622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogen-activated protein kinase kinase 4 (MKK4).
    Cuenda A
    Int J Biochem Cell Biol; 2000 Jun; 32(6):581-7. PubMed ID: 10785355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer.
    Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM
    Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
    Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
    Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
    Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
    Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
    Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
    Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.